Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬1. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 2 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬1. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 3 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬3. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 4 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬3. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 5 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬5. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 6 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬5. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 7 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 8 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 9 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A [1] PDE5A 💬cGMP-PKG signaling pathway
|
Sildenafil citrate Sildenafil citrate 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬9. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 10 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A [1] PDE5A 💬cGMP-PKG signaling pathway
|
Sildenafil Sildenafil 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬9. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 11 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Hormone signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬11. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 12 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Hormone signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬11. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 13 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬13. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 14 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬13. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 15 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬15. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 16 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬15. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 17 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬17. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 18 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬17. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 19 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 20 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 21 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬21. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 22 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬21. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 23 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬23. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 24 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬23. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 25 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬25. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 26 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬25. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 27 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A [1] PDE5A 💬Purine metabolism
|
Sildenafil citrate Sildenafil citrate 💬Purine metabolism
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬27. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||
| 28 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A [1] PDE5A 💬Purine metabolism
|
Sildenafil Sildenafil 💬Purine metabolism
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬27. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||
| 29 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬29. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 30 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬29. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 31 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬31. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 32 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬31. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 33 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬33. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 34 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬33. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 35 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬35. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 36 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬35. Vascular smooth muscle contraction
|
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Melanogenesis
7 genes, 18 drugs (DrugBank) and 34 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Purine metabolism
30 genes, 44 drugs (DrugBank) and 82 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Thyroid hormone signaling pathway
25 genes, 46 drugs (DrugBank) and 78 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases
